Cardiovascular manifestations in HIV-infected patients: a cross-sectional study from a tertiary care hospital

Nayana Rajan; Anita Paritekar

doi:10.18203/2320-6012.ijrms20262638

Authors

Nayana Rajan General Medicine, Rajarshee Chhatrapati Shahu Maharaj Government Medical College and CPR Hospital, Kolhapur, Maharashtra, India
Anita Paritekar General Medicine, Rajarshee Chhatrapati Shahu Maharaj Government Medical College and CPR Hospital, Kolhapur, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20262638

Keywords:

Cardiovascular manifestations, CD4 count, Cardiomyopathy, Echocardiography, HIV

Abstract

Background: Human Immunodeficiency Virus (HIV) infection is associated with various cardiovascular manifestations, many of which remain asymptomatic and contribute significantly to morbidity. The present study was conducted to evaluate the prevalence and spectrum of cardiovascular manifestations among HIV-infected patients and to assess their association with CD4 counts and antiretroviral therapy adherence.

Methods: This hospital-based cross-sectional study included 100 HIV-positive patients admitted to a tertiary care hospital between October 2019 and April 2021. Detailed clinical evaluation along with laboratory investigations including CD4 count, electrocardiography, chest radiography and two-dimensional echocardiography were performed in all patients. Coronary angiography was performed in selected patients when clinically indicated.

Results: Cardiovascular abnormalities were observed in 48% of patients, of which 64.5% were asymptomatic. Diastolic dysfunction was the most common echocardiographic abnormality (36%), followed by systolic dysfunction (23%), dilated cardiomyopathy (11%) and pericardial effusion (9%). Lower CD4 counts and anemia were significantly associated with cardiovascular involvement.

Conclusions: Cardiovascular manifestations are common in HIV-infected patients and often remain clinically silent. Routine cardiac evaluation, particularly echocardiography, may help in early detection of cardiac involvement in these patients.

References

Triant VA. HIV infection and coronary heart disease. J Infect Dis. 2012;205(3):355-63.

Freiberg MS, So-Armah K. HIV and cardiovascular disease. Circulation. 2016;133(21):2167-79.

Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019;16(12):745-59.

Mondy KE, Gottdiener J, Overton ET, Henry K, Bush T, Conley L, et al. High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis. 2011;52(3):378-86.

Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection: prognostic implications. BMJ. 1994;309(6969):1605-7.

Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome. AIDS. 1998;12(18):2499-508.

Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation. 1995;92(11):3229-34.

Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of echocardiographic abnormalities in HIV-infected African patients. Trop Doct. 2007;37(4):218-22.

Barbaro G. Dilated cardiomyopathy in HIV infection. N Engl J Med. 1998;339(16):1093-9.

Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS. 2008;22(13):1615-24.

Friis-Moller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993-2003.

Anand IS. Anemia and chronic heart failure: implications and treatment options. J Am Coll Cardiol. 2008;52(7):501-11.